
In the zzso trial zzso zzso a trend favoring viral suppression was seen in the zzso subjects who received a zzso zzso zzso gag zzso 

To identify individuals with initial viral suppression zzso zzso zzso set point zzso zzso zzso during the zzso treatment interruption zzso and evaluate the durability and zzso of zzso control and characteristics of zzso sequence zzso 

zzso gag and pol zzso were amplified and zzso from plasma obtained during the zzso zzso responses were measured by flow zzso analysis and zzso zzso expression zzso zzso of those with and without initial viral suppression were compared using the zzso rank sum and zzso exact zzso 

Eleven out of 104 participants zzso were classified as initial zzso zzso nine of whom had received the zzso zzso zzso zzso had significantly less zzso cell decline by ATI week 16 as compared to zzso zzso 7 zzso cell gain zzso 247 zzso cell loss, zzso However, of the ten initial zzso zzso with a zzso at ATI week 49, only three maintained zzso zzso zzso zzso zzso zzso zzso zzso responses were not associated with initial zzso suppression and no evidence of zzso zzso sequence evolution was zzso Participants with initial zzso suppression were found to have a lower percentage of zzso zzso cells prior to treatment zzso but a greater proportion of zzso zzso zzso zzso cells expressing either zzso or zzso 

Among individuals participating in a zzso therapeutic zzso gag vaccine trial, initial viral suppression was found in a subset of patients, but this response was not zzso The association between zzso and zzso expression on zzso T cells and zzso outcome warrants further study in trials of other therapeutic vaccines in zzso 

zzso zzso 

